Delta4 Programs
Development Program
FSGS, a kidney disorder tied to nephrotic syndrome, lacks specific treatments. Current options are limited, and many patients face kidney failure, requiring dialysis or transplantation.
Development Program
ADPKD, a common genetic kidney disease, often leads to kidney failure, with many requiring dialysis or transplantation. Current treatments, have limitations, highlighting the need for better therapies.
Development Program
Globally, over 850 million people are affected by kidney diseases, with CKD mortality rising rapidly and expected to become a leading cause of death. Novel treatments are urgently needed to prevent AKI and its progression to CKD.
Development Program
Prostate cancer affects ~1.3 million men annually, with a treatment paradox: slow-growing cases are often overtreated, while advanced-stage cancer lacks effective cures. Improved management and targeted treatments are urgently needed.
Development Program
PBC and PSC are chronic liver diseases that can lead to liver failure and transplantation. With no cure available, current treatments are limited, highlighting the need for new therapies to halt disease progression.
Development Program
Anosmia is the loss of smell, which can be temporary or permanent, often caused by factors like viral infections. It is a common neurological symptom of COVID-19, affecting up to 55% of patients.
Scientist.com provides a unique platform where researchers and suppliers can both find each other and work together more easily. They provide a collaboration framework to streamline the typically long and tedious process of defining the terms and conditions of an agreement.
Members can work together smoothly and effortlessly by agreeing to the rules of the platform. The result is that together we can achieve the results we need faster.
Notifications
